Andrew Kritzer
Nurse Practitioner · Dalton, GANPI 1811061021
Payments from drug & device makers
Across 141 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$413
- Novo Nordisk$359
- AstraZeneca$327
- AbbVie$261
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$260
- Curonix LLC$191
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 6 | $413 |
| Novo Nordisk | 12 | $359 |
| AstraZeneca | 13 | $327 |
| AbbVie | 18 | $261 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $260 |
| Curonix LLC | 4 | $191 |
| Spinal Simplicity, LLC | 1 | $163 |
| Amgen(2 entities) | 9 | $149 |
| Stryker | 1 | $139 |
| Collegium Pharmaceutical, Inc. | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Lilly USA, LLC | 5 | $92 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Foundation Fusion Solutions, LLC | 1 | $89 |
| Scilex Pharmaceuticals Inc. | 3 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $48 |
| Abbott | 2 | $44 |
| Pfizer | 2 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Eisai Inc. | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Vertex | 1 | $33 |
| Bayer | 2 | $32 |
| Shield Therapeutics Inc | 2 | $27 |
| Johnson & Johnson | 1 | $27 |
| Edwards Lifesciences | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Valinor Pharma, LLC | 1 | $14 |
| Corium, LLC | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$163
- mild Device Kit$139
- RYBELSUS$125
How this compares
$3,396 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 52 | $126,285 |
| OzempicSemaglutide | 29 | $31,447 |
| MovantikNaloxegol Oxalate | 66 | $26,402 |
| FarxigaDapagliflozin Propanediol | 14 | $13,340 |
| LinzessLinaclotide | 19 | $9,990 |
| Lidocaine | 81 | $7,171 |
| ZtlidoLidocaine | 12 | $6,774 |
| Gabapentin | 524 | $5,575 |
| Tizanidine Hcl | 336 | $3,771 |
| Diclofenac Sodium | 115 | $3,740 |
| Cyclobenzaprine Hcl | 217 | $1,747 |
| Methocarbamol | 90 | $908 |
| Celecoxib | 61 | $896 |
| Baclofen | 84 | $672 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 33 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $260 | $126,28552 claims |
| Novo NordiskOzempic | $359 | $31,44729 claims |
| AstraZenecaFarxiga | $327 | $13,34014 claims |
| AbbVieLinzess | $261 | $9,99019 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $49 | $6,77412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Dalton
- Victor CzerkasijDalton$505K
- Lindsay BrightDalton$28K
- Cynthia WittDalton$10K
- Crystal LogsdonSavannah$566K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.